Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

2025 Diagnostics Market Research Review Report

globenewswire.com
ABT Abbott is mentioned as a major firm in the diagnostics market, which is experiencing growth and technological advancements, but also increased scrutiny and competition. MDT Medtronic is listed as a major player in the diagnostics industry, which is undergoing changes due to regulations and technological innovation, facing both opportunities and challenges. AGNC Agilent Technologies Inc. is identified as a significant company within the diagnostics market, which is characterized by growth, innovation, and increasing competition. DHR Danaher Corp. is named as a major firm in the diagnostics sector, which is experiencing growth driven by technological advances and increasing disease prevalence, alongside regulatory pressures. TMO Thermo Fisher Scientific Inc. is mentioned as a key company in the diagnostics market, which is poised for growth due to technological advancements and demand for better healthcare solutions, but also faces intense competition. BDX BD is listed as a major participant in the diagnostics industry, which is seeing growth and innovation, but also increased regulatory oversight and competition. GEHC GE Healthcare is named as a major firm in the diagnostics market, which is experiencing growth and technological advancements, but also increased scrutiny and competition.

2025 Diagnostics Market Research Review Report Dublin, April 23, 2026 (GLOBE NEWSWIRE) -- The "2025 Diagnostics Research Review" report has been added to ResearchAndMarkets.com's offering.

The diagnostics industry has grown despite the challenging economic conditions in recent years. The industry draws much attention and scrutiny from the public and government, and is currently undergoing many changes due to increased focus on regulations.

These changes can be seen across many countries. The U.S., the largest diagnostics market, is leading the trend with changes intended to make healthcare more affordable. Opportunities for the diagnostics industry are manifold, with the appearance of new markets located mainly in emerging economies with varying needs.

Increasing healthcare expenditures and the growth of emerging economies have increased the demand for technologically better diagnostic devices, kits, reagents, and other accessories. Additionally, the introduction of more stringent regulations, specifically in the developed markets of the U.S. and Europe, has forced diagnostics manufacturers to launch advanced products that include new materials, a focus on in-depth indications, and the ability to produce additional new data.

Some of the major driving factors in the market are the increasing prevalence of chronic and infectious diseases, technological advances in diagnostics, increasing investments in AI in the diagnostics market, increased applications in non-oncology areas, and growing adoption of personalized medicine.

Furthermore, technically sophisticated diagnostics are needed for clinical research, as the market is highly competitive, and companies must continuously reinvent their product portfolios to enter new markets and place themselves as key participants in the healthcare system. There is a shift toward a value-based healthcare market where price and purchase decisions are based on outcomes.

This has further led to increased scrutiny of device technology, and consequently, the degree of competition has risen. Some of the major firms in the diagnostics market include Abbott, Medtronic, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Agilent Technologies Inc., QIAGEN, Danaher Corp., Sysmex, Thermo Fisher Scientific Inc., BD, and others.

The diagnostics industry is a multi-billion-dollar market with an outlook for continued growth in the coming years. Hospital care is growing, and the diagnostics industry is being looked at to provide low-cost technology for home healthcare. Now, the industry seeks healthcare diagnostic devices, kits, and reagents that individuals with unskilled healthcare experience can use. The need for modern technology, equipment, and devices can be leveraged through diagnostic equipment as manufacturers seek to create better-quality healthcare solutions.

The above reasons are compelling enough to analyze and research the diagnostics market, as the market has tremendous growth potential.

Key Market Valuations:

Key Topics Covered:

Chapter 1 Foreword

Chapter 2 Tissue Diagnostics: Technologies and Global Markets

Chapter 3 Global Colorectal Cancer Screening and Diagnostics Market

Chapter 4 Oncology Diagnostics: Global Markets

Chapter 5 Liquid Biopsy Research Tools, Services and Diagnostics

Chapter 6 Human Microbiome-based Drugs and Diagnostics

Chapter 7 Molecular Diagnostics: Technologies and Global Markets

Chapter 8 In Vitro Diagnostics: Technologies and Global Markets

Chapter 9 Global Markets for Allergy Diagnostics and Treatments

Chapter 10 Noninvasive Cancer Diagnostics: Technologies and Global Markets

Chapter 11 Global Markets for Diabetes Therapeutics and Diagnostics

Chapter 12 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/pszr95

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.